LLY-507

N/A

Report date: 2022/10/26 14:07:47
NME

Base Information

Drug NameLLY-507
Drug Alias NameLLY-507
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionN-lysine methyltransferase SMYD2 inhibitors
TargetsN-lysine methyltransferase SMYD2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A